New research published in Science Translational Medicine confirms that brain-computer interface (BCI) technology can provide a safe, lasting artificial sense of touch for individuals with spinal cord injuries. According to the University of Pittsburgh, a study involving five participants found that intracortical microstimulation remained functional and effective for years, marking a significant milestone for the future of clinical neural implants.
Decade-Long Safety and Stability of Neural Implants
The study, conducted in collaboration with the University of Chicago, represents the longest-running safety analysis of intracortical microstimulation in humans to date. Researchers delivered 168 million pulses of brain stimulation across five volunteers over a combined 27 years of implant time. According to Robert Gaunt, a professor of physical medicine and rehabilitation at the University of Pittsburgh, the data proves these devices can withstand the rigors of daily use.
The findings showed that sensations remained mapped to the hand, preventing the “drift” to other parts of the body. Furthermore, the stimulation did not cause painful or lingering sensations. On average, only one persistent sensation occurred per 23,000 trials, and these instances typically resolved in under 10 seconds. This stability is critical for transitioning BCIs from experimental research into clinical settings and, eventually, home use.
Did you know?
Despite the biological challenges of implanting technology, such as the body’s natural response to foreign objects, the study found that 64% of electrodes remained functional on average, with one participant maintaining 60% functionality over a decade.
Overcoming Hardware and Biological Limitations
While the results are promising, the technology faces inherent hurdles. The devices used in the study were manufactured by BlackRock Neurotech about 20 years ago. Over time, materials decayed, and the brain’s response—similar to the rejection of an organ transplant—reduced the sensitivity of the electrodes.
Gaunt noted that these results were achieved using a 20-year-old piece of technology, which suggests that next-generation devices could yield even better results. The study provides a “flag in the ground” for the safety benchmarks required to move toward commercialization.
Broader Implications for Sensory Restoration
The success of this BCI study extends beyond spinal cord injury recovery. Researchers are currently exploring similar stimulation methods to restore vision and hearing. By bypassing damaged sensory cells and stimulating the brain directly, these interfaces could offer new pathways for patients with various sensory disabilities.
For example, cortical vision prosthetics aim to restore partial sight by bypassing damaged eye cells and stimulating the visual cortex. According to the University of Pittsburgh, proving that long-term electrical stimulation is safe for the brain provides a vital foundation for these visual systems. As clinical confidence grows, the timeline for commercializing these interfaces continues to shorten.
Frequently Asked Questions
- Can these devices distinguish between different textures?
Not yet. Current technology allows users to feel tingling or buzzing sensations to manipulate objects, but it cannot yet differentiate between materials like silk, satin, or wood. - Are these implants safe for long-term use?
According to the University of Pittsburgh study, 168 million pulses were delivered over 27 cumulative years without any serious adverse events. - When will these devices be available commercially?
Robert Gaunt estimates that the first generation of commercial BCIs may reach the broader market within a couple of years.
Pro Tip:
Follow UPMC and University of Chicago research portals to stay updated on the latest clinical trial phases for neural prosthetics.
Are you interested in the intersection of neuroscience and technology? Subscribe to our newsletter for the latest updates on neuroprosthetics and advancements in medical engineering.
Related reading
